1. Bisphenol S and Epidermal Growth Factor Receptor Signaling in Human Placental Cytotrophoblasts
   Elvis Ticiani et al, 2021, Environ Health Perspect CrossRef
2. Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
   Kyu Sic You et al, 2021, Cancers CrossRef
3. The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population
   Li Zhang et al, 2021, PGPM CrossRef
4. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
   Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
5. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
   Yong Weon Yi et al, 2021, IJMS CrossRef
6. Identifying Key Lysosome-Related Genes Associated with Drug-Resistant Breast Cancer Using Computational and Systems Biology Approach
   Aref Shiralipour et al, 2022, Iran J Pharm Res CrossRef
7. Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine
   Trishna Saha Detroja et al, 2022, IJMS CrossRef
8. Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells
   Yong Weon Yi et al, 2022, Cancers CrossRef
9. Dark Sweet Cherry (Prunus avium) Anthocyanins Suppressed ERK1/2-Akt/mTOR Cell Signaling and Oxidative Stress: Implications for TNBC Growth and Invasion
   Ana Carolina Silveira Rabelo et al, 2022, Molecules CrossRef
10. Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
    Jing Ma et al, 2023, BCTT CrossRef
11. RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma
    Yanfang Jiang et al, 2023, Invest New Drugs CrossRef
12. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding
    Ying Lin et al, 2024, J Exp Clin Cancer Res CrossRef